AptaBio Therapeutics Inc. (293780.KQ)
KRW 8040.0
(2.03%)
KRW 8040.0
(2.03%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -12.08 Billion KRW | -360.62% |
| 2022 | -2.62 Billion KRW | 59.43% |
| 2021 | -6.46 Billion KRW | 55.79% |
| 2020 | -14.62 Billion KRW | 11.44% |
| 2019 | -16.51 Billion KRW | -283.05% |
| 2018 | -4.31 Billion KRW | -74.35% |
| 2017 | -2.47 Billion KRW | 45.69% |
| 2016 | -4.55 Billion KRW | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -22.34 Billion KRW | -98.2% |
| 2024 Q1 | -11.27 Billion KRW | 6.69% |
| 2023 Q3 | -16.62 Billion KRW | -192.36% |
| 2023 FY | -12.08 Billion KRW | -360.62% |
| 2023 Q4 | -12.08 Billion KRW | 27.33% |
| 2023 Q2 | -5.68 Billion KRW | 5.56% |
| 2023 Q1 | -6.02 Billion KRW | -129.58% |
| 2022 Q2 | -11.31 Billion KRW | 12.02% |
| 2022 Q1 | -12.86 Billion KRW | -99.01% |
| 2022 Q4 | -2.62 Billion KRW | 65.12% |
| 2022 Q3 | -7.52 Billion KRW | 33.55% |
| 2022 FY | -2.62 Billion KRW | 59.43% |
| 2021 Q1 | -11.38 Billion KRW | 22.46% |
| 2021 FY | -6.46 Billion KRW | 55.79% |
| 2021 Q4 | -6.46 Billion KRW | 51.04% |
| 2021 Q3 | -13.2 Billion KRW | 3.74% |
| 2021 Q2 | -13.71 Billion KRW | -20.46% |
| 2020 Q2 | -16.9 Billion KRW | -71.63% |
| 2020 FY | -14.62 Billion KRW | 11.44% |
| 2020 Q4 | -14.68 Billion KRW | -30.17% |
| 2020 Q3 | -11.28 Billion KRW | 33.25% |
| 2020 Q1 | -9.84 Billion KRW | 40.68% |
| 2019 Q2 | -22.72 Billion KRW | 0.0% |
| 2019 Q4 | -16.6 Billion KRW | -8.11% |
| 2019 Q3 | -15.35 Billion KRW | 32.42% |
| 2019 FY | -16.51 Billion KRW | -283.05% |
| 2018 Q4 | -4.31 Billion KRW | 0.0% |
| 2018 FY | -4.31 Billion KRW | -74.35% |
| 2017 FY | -2.47 Billion KRW | 45.69% |
| 2016 FY | -4.55 Billion KRW | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| HLB Pharmaceutical Co., Ltd | 18.96 Billion KRW | 163.721% |
| CMG Pharmaceutical Co., Ltd. | 18.78 Billion KRW | 164.322% |
| Celltrion Pharm, Inc. | 142.81 Billion KRW | 108.46% |
| Huons Global Co., Ltd. | 13.26 Billion KRW | 191.084% |
| DongKook Pharmaceutical Co., Ltd. | 44.19 Billion KRW | 127.339% |
| Enzychem Lifesciences Corporation | -9.81 Billion KRW | -23.122% |
| Humedix Co., Ltd. | -77.54 Billion KRW | 84.419% |
| Boditech Med Inc. | -31.92 Billion KRW | 62.156% |
| EuBiologics Co., Ltd. | 4.88 Billion KRW | 347.512% |
| FutureChem Co.,Ltd | -4.93 Billion KRW | -145.045% |
| Huons Co., Ltd. | 73.9 Billion KRW | 116.347% |
| BNC Korea Co., Ltd. | -67.65 Billion KRW | 82.14% |